Compare Adaptive Biotechnologies Corp (ADPT) vs CDW Corp. (CDW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs CDW Corp. — how do they compare? Adaptive Biotechnologies Corp trades at $20.19 (market cap $3.33B), while CDW Corp. trades at $137.86 (market cap $17.79B). The key difference: CDW Corp. is far larger — about 5.3× Adaptive Biotechnologies Corp's market cap, and CDW Corp. pays a 1.81% dividend while Adaptive Biotechnologies Corp pays none. Which is the better fit depends on your goals.
| ADPT | CDW | |
|---|---|---|
Market Cap | $3.33B | $17.79B |
Sector | Health | Technology |
52-Week High | $22.37 | $182.18 |
52-Week Low | $10.24 | $99.30 |
Enterprise Value | $3.19B | $23.00B |
Dividend Yield | — | 1.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About CDW Corp.
CDW Corp is a value-added reseller operating in the U.S. (95% of sales) and Canada (5%). The company has more than 100,000 products on its line of cards that range from notebooks to data center software. Roughly half of CDW's revenue comes from midsize and large businesses, with the remaining from small businesses, government agencies, education institutions, and health-care organizations.
Read more on CDW →
